These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16407702)

  • 1. Intracardiac devices for stroke prevention.
    Nageh T; Meier B
    Prev Cardiol; 2006; 9(1):42-8. PubMed ID: 16407702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left atrial appendage closure for "primary primary" prevention during percutaneous closure of septal defects in patients with large atria but no atrial fibrillation.
    Kuwata S; Vierecke J; Gloekler S; Maisano F; Meier B; Nietlispach F
    Cardiol J; 2018; 25(2):179-187. PubMed ID: 28840592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventional treatments for stroke prevention in atrial fibrillation with emphasis upon the WATCHMAN device.
    Möbius-Winkler S; Schuler GC; Sick PB
    Curr Opin Neurol; 2008 Feb; 21(1):64-9. PubMed ID: 18180653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.
    Grosset-Janin D; Barth E; Bertrand B; Detante O
    Rev Neurol (Paris); 2015 May; 171(5):426-32. PubMed ID: 25912470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left atrial appendage closure for stroke prevention in atrial fibrillation: state of the art and current challenges.
    Syed TM; Halperin JL
    Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):428-35. PubMed ID: 17653115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage.
    Majunke N; Wallenborn J; Wunderlich N; Sievert H
    Minerva Cardioangiol; 2009 Feb; 57(1):103-15. PubMed ID: 19202522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombus in the right atrial appendage during pulmonary and paradoxical embolism: a case report.
    Huang G; Pavan D; Antonini-Canterin F; Piazza R; Cassin M; Nicolosi GL
    Ital Heart J; 2002 Aug; 3(8):486-9. PubMed ID: 12407828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation: is left atrial appendage closure an alternative for anticoagulation?].
    Boersma LVA; Rensing BJWM; Wintgens LI; Klaver M; Swaans MJ
    Ned Tijdschr Geneeskd; 2018 Jun; 162():. PubMed ID: 30040296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptogenic Strokes and Patent Foramen Ovales: What's the Right Treatment?
    Dalen JE; Alpert JS
    Am J Med; 2016 Nov; 129(11):1159-1162. PubMed ID: 27566504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous devices for stroke prevention.
    Bayard YL; Ostermayer SH; Hein R; Skowasch M; Büscheck F; Baranowski A; Heinisch C; Sievert H
    Cardiovasc Revasc Med; 2007; 8(3):216-25. PubMed ID: 17765654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of patients with stroke and a patent foramen ovale.
    Rodriguez CJ; Homma S
    Curr Cardiol Rep; 2004 Mar; 6(2):143-6. PubMed ID: 14759360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Devices to decrease stroke risk.
    Tuzcu EM
    J Invasive Cardiol; 2004 Jul; 16(7 Suppl):54S-58S. PubMed ID: 23573575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patent foramen ovale and cryptogenic stroke. A critical review.
    Ballerini L; Cifarelli A; Ammirati A; Gimigliano F
    J Cardiovasc Med (Hagerstown); 2007 Jan; 8(1):34-8. PubMed ID: 17255814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke prevention in atrial fibrillation with left atrial appendage closure.
    Zack CJ; Fender EA; Holmes DR
    Minerva Med; 2017 Jun; 108(3):199-211. PubMed ID: 28001014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
    Le D; Morelli R; Badhwar N; Lee RJ
    Expert Rev Cardiovasc Ther; 2015; 13(8):907-14. PubMed ID: 26070218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patent foramen ovale and left atrial appendage: new devices and methods for closure.
    Hein R; Bayard Y; Taaffe M; Büscheck F; Ostermayer S; Billinger K; Reschke M; Trepels T; Lissmann-Jensen H; Lang K; Römer A; Wilson N; Sievert H
    Pediatr Cardiol; 2005; 26(3):234-40. PubMed ID: 16132300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patent foramen ovale: paradoxical connection to migraine and stroke.
    Diener HC; Weimar C; Katsarava Z
    Curr Opin Neurol; 2005 Jun; 18(3):299-304. PubMed ID: 15891416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent foramen ovale and recurrent stroke: closure is the best option: yes.
    Furlan AJ
    Stroke; 2004 Mar; 35(3):803-4. PubMed ID: 14963269
    [No Abstract]   [Full Text] [Related]  

  • 20. [Left atrial appendage closure in non-valvular atrial fibrillation].
    Häusler KG; Landmesser U
    Herz; 2019 Jun; 44(4):310-314. PubMed ID: 31076823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.